ARTICLE | Company News
Gold Coast Therapeutics, Insys deal
March 16, 2015 7:00 AM UTC
Gold Coast granted Insys an exclusive sublicense to develop a combination of cromolyn sodium and cetirizine to treat chronic prostatitis/chronic pelvic pain syndrome ( CP/CPPS). Gold Coast has exclusi...